Intuitive Surgical Q3 2026 Earnings Results

Intuitive Surgical reports 22% revenue growth and 15% procedure expansion in Q3 2026.

20 cards · 2m · tap to begin

From · · · 2m

Intuitive Surgical Q3 2026 Earnings Results

Intuitive Surgical reports 22% revenue growth and 15% procedure expansion in Q3 2026.

In brief

Intuitive Surgical reports 22% revenue growth and 15% procedure expansion in Q3 2026. Intuitive Surgical reported $3.05 billion revenue with 15% procedure growth and $3.00 non-GAAP EPS for Q3 2026. Originally reported by The Motley Fool.

Q3 2026 Results

Intuitive Surgical reported total revenue of $3.05 billion, up 22% from Q3 2025.

Non-GAAP EPS

Non-GAAP EPS reached $3.00, a 25% year-over-year increase.

Procedure Growth

live-1023-meta-tsla.png

Total procedure growth reached 15% with 14% da Vinci and 31% Ion growth.

U.S. Da Vinci Growth

U.S. da Vinci procedures grew 10% year-over-year, consistent with expectations.

International Da Vinci Growth

International da Vinci procedures grew 20% year-over-year, led by Europe and Japan.

System Placements

Cathie Wood_ARK Investment Management_CEO_imageSource_Getty Images_3

546 da Vinci systems placed, up 28% from 427 units in Q3 2025.

Da Vinci 5 Placements

315 da Vinci 5 systems placed, representing 58% of total da Vinci placements.

Installed Base

13,246 total systems installed, up 13% year-over-year.

I&A Revenue

robots-androids-business-suits

I&A revenue grew to $1.80 billion, up 18% year-over-year.

I&A Revenue Per Procedure

I&A revenue per procedure increased to $1,860 from $1,800 last year.

Pricing Actions

3% to 5% reduction in I&A revenue per procedure expected from pricing actions.

Operating Margin

GettyImages-2271129407-1200x800-5b2df79

Non-GAAP operating margin reached 42%, up from 41% excluding tariff refunds.

Gross Margin

Non-GAAP gross margin at 69.9%, down from 68.9% excluding tariff refunds.

SP Procedure Growth

SP procedures grew 55% globally, driven by 50% U.S. growth and 40% Korea growth.

Ion Placements

56 Ion systems placed, up from 50 systems in Q3 2025.

Share Repurchases

Share repurchases of $2.94 billion at $377 per share.

Procedure Growth Guidance

Full year 2026 procedure growth guidance narrowed to 14% to 15%.

Litigation Settlement

Agreed $450 million settlement for antitrust class action litigation.

Ambulatory Surgery Centers

18 systems installed at U.S. ambulatory surgery centers.

Cardiac Procedure Opportunity

300,000 to 400,000 annual cardiac procedures expected.

The one thing

Intuitive Surgical reported $3.05 billion revenue with 15% procedure growth and $3.00 non-GAAP EPS for Q3 2026.

Read the original on The Motley Fool

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on intuitive surgical and related topics.